FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $178,886 | -79.3% | 66,254 | +42.9% | 0.01% | -81.1% |
| Q1 2023 | $865,190 | +91.0% | 46,366 | +172.8% | 0.05% | +253.3% |
| Q2 2021 | $453,000 | -24.6% | 16,994 | -1.9% | 0.02% | -34.8% |
| Q1 2021 | $601,000 | -14.0% | 17,328 | -8.1% | 0.02% | -25.8% |
| Q4 2020 | $699,000 | +0.3% | 18,858 | +11.2% | 0.03% | -13.9% |
| Q3 2020 | $697,000 | -10.2% | 16,956 | -11.5% | 0.04% | -16.3% |
| Q2 2020 | $776,000 | +38.8% | 19,151 | +19.0% | 0.04% | +2.4% |
| Q1 2020 | $559,000 | -42.8% | 16,088 | -29.4% | 0.04% | -2.3% |
| Q4 2019 | $977,000 | +33.1% | 22,772 | +14.7% | 0.04% | +16.2% |
| Q3 2019 | $734,000 | -20.6% | 19,848 | -3.1% | 0.04% | -15.9% |
| Q2 2019 | $925,000 | -23.6% | 20,484 | -8.0% | 0.04% | -24.1% |
| Q1 2019 | $1,210,000 | +17.7% | 22,261 | +0.2% | 0.06% | -9.4% |
| Q4 2018 | $1,028,000 | -38.8% | 22,209 | -19.6% | 0.06% | 0.0% |
| Q3 2018 | $1,679,000 | – | 27,632 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 1,735,677 | $93,379,000 | 12.44% |
| Omega Fund Management, LLC | 314,348 | $16,912,000 | 9.57% |
| Opaleye Management Inc. | 360,000 | $19,368,000 | 6.85% |
| NEXTHERA CAPITAL LP | 217,329 | $11,692,000 | 3.01% |
| Monashee Investment Management LLC | 122,300 | $6,580,000 | 2.49% |
| Hillhouse Capital Management | 2,486,196 | $133,757,000 | 2.21% |
| DOHENY ASSET MANAGEMENT /CA | 50,925 | $2,740,000 | 1.26% |
| Sicart Associates LLC | 31,072 | $1,672,000 | 1.20% |
| Iguana Healthcare Management, LLC | 80,000 | $4,304,000 | 1.19% |
| Rhenman & Partners Asset Management AB | 145,500 | $7,828,000 | 1.00% |